Next Article in Journal
Evaluation of the Anticancer Potential of Crude, Irradiated Cerastes cerastes Snake Venom and Propolis Ethanolic Extract & Related Biological Alterations
Next Article in Special Issue
Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment
Previous Article in Journal
Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding
Previous Article in Special Issue
Selective Oxidation of Clopidogrel by Peroxymonosulfate (PMS) and Sodium Halide (NaX) System: An NMR Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

Drug Design: Where We Are and Future Prospects

1
Department of Pharmaceutical Sciences, University of Padova, Via Marzolo 5, 35131 Padova, Italy
2
Institute of Computational Chemistry and Catalysis (IQCC) and Department of Chemistry, Faculty of Sciences, University of Girona, C/M. A. Capmany 69, 17003 Girona, Spain
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(22), 7061; https://doi.org/10.3390/molecules26227061
Submission received: 19 October 2021 / Revised: 15 November 2021 / Accepted: 17 November 2021 / Published: 22 November 2021

Abstract

Medicinal chemistry is facing new challenges in approaching precision medicine. Several powerful new tools or improvements of already used tools are now available to medicinal chemists to help in the process of drug discovery, from a hit molecule to a clinically used drug. Among the new tools, the possibility of considering folding intermediates or the catalytic process of a protein as a target for discovering new hits has emerged. In addition, machine learning is a new valuable approach helping medicinal chemists to discover new hits. Other abilities, ranging from the better understanding of the time evolution of biochemical processes to the comprehension of the biological meaning of the data originated from genetic analyses, are on their way to progress further in the drug discovery field toward improved patient care. In this sense, the new approaches to the delivery of drugs targeted to the central nervous system, together with the advancements in understanding the metabolic pathways for a growing number of drugs and relating them to the genetic characteristics of patients, constitute important progress in the field.
Keywords: drug discovery; precision medicine; pharmacodynamics; pharmacokinetics drug discovery; precision medicine; pharmacodynamics; pharmacokinetics
Graphical Abstract

Share and Cite

MDPI and ACS Style

Zagotto, G.; Bortoli, M. Drug Design: Where We Are and Future Prospects. Molecules 2021, 26, 7061. https://doi.org/10.3390/molecules26227061

AMA Style

Zagotto G, Bortoli M. Drug Design: Where We Are and Future Prospects. Molecules. 2021; 26(22):7061. https://doi.org/10.3390/molecules26227061

Chicago/Turabian Style

Zagotto, Giuseppe, and Marco Bortoli. 2021. "Drug Design: Where We Are and Future Prospects" Molecules 26, no. 22: 7061. https://doi.org/10.3390/molecules26227061

APA Style

Zagotto, G., & Bortoli, M. (2021). Drug Design: Where We Are and Future Prospects. Molecules, 26(22), 7061. https://doi.org/10.3390/molecules26227061

Article Metrics

Back to TopTop